Core Viewpoint - Chao Yan Co., Ltd. has shown a slight increase in stock price and trading volume, with notable financing activities indicating investor interest and potential growth in the medical imaging and industrial non-destructive testing sectors [1][2]. Financing and Trading Activity - On October 24, Chao Yan Co., Ltd. experienced a stock price increase of 0.52% with a trading volume of 56.81 million yuan. The financing buy-in amounted to 3.27 million yuan, while the financing repayment was 4.04 million yuan, resulting in a net financing outflow of 0.77 million yuan. The total financing and securities balance reached 92.15 million yuan [1]. - The current financing balance is 91.98 million yuan, representing 6.30% of the circulating market value. In terms of securities lending, 1,200 shares were repaid with no shares sold on October 24, leading to a remaining securities lending balance of 6,800 shares valued at 170,100 yuan [1]. Company Performance - As of June 30, the number of shareholders for Chao Yan Co., Ltd. was 22,300, a decrease of 16.65% from the previous period. The average circulating shares per person increased by 19.98% to 2,456 shares. For the first half of 2025, the company reported a revenue of 184 million yuan, reflecting a year-on-year growth of 15.00%, and a net profit attributable to shareholders of 68.45 million yuan, up 18.50% year-on-year [2]. - Since its A-share listing, Chao Yan Co., Ltd. has distributed a total of 43.69 million yuan in dividends [3]. Shareholder Composition - As of June 30, 2025, the largest shareholder among the top ten circulating shareholders is Huabao Zhongzheng Medical ETF, holding 1.91 million shares as a new shareholder. The second-largest is Southern Zhongzheng 1000 ETF with 514,500 shares, also a new shareholder. Hong Kong Central Clearing Limited is the fourth-largest shareholder with 470,000 shares, having increased its holdings by 21,600 shares compared to the previous period [3].
超研股份10月24日获融资买入327.46万元，融资余额9197.85万元